Carcinogenesis, Vol. 22, No. 11, 1747-1755,
November 2001
© 2001 Oxford University Press
CANCER BIOLOGY |
Tetradecylthioacetic acid inhibits growth of rat glioma cells ex vivo and in vivo via PPAR-dependent and PPAR-independent pathways
Department of Clinical Biochemistry, Haukeland Hospital, University of Bergen, N-5021 Bergen, Norway,
1 Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M and
2 Department of Environmental Medicine, Institute of Community Health, University of Southern Denmark, DK-5230 Odense M, Denmark
The peroxisome proliferator-activated receptors (PPARs) are transcription factors involved in fatty acid metabolism and energy homeostasis. The PPARs also play crucial roles in the control of cellular growth and differentiation. Especially, the recently emerged concept of ligand-dependent PPAR
-mediated inhibition of cancer cell proliferation through induction of G1-phase arrest and differentiation is of clinical interest to cancer therapy. Tetradecylthioacetic acid (TTA) is a sulphur-substituted saturated fatty acid analog with unique biochemical properties. In this study, we investigated the effects of TTA-administration on cell proliferation in glioma cancer models. The rat glioma cell line BT4Cn, whether grown in culture or implanted in rats, expressed significant levels of PPAR and PPAR
, with PPAR being the predominant PPAR subtype. In BT4Cn cells, TTA activated all PPAR subtypes in a dose-dependent manner. In cell culture experiments, the PPAR-selective ligand BRL49653 moderately inhibited growth of BT4Cn cells, whereas administration of TTA resulted in a marked growth inhibition. Administration of the PPAR-selective antagonist GW9662 abolished BRL49653-induced growth inhibition, but only marginally reduced the effect of TTA. TTA reduced tumor growth and increased the survival time of rats with implanted BT4Cn tumor. TTA-induced apoptosis in BT4Cn cells, and the administration of TTA led to cytochrome c release from mitochondria and increased the glutathione content in glioma cells. In conclusion, our results indicate that TTA inhibits proliferation of glioma cancer cells through both PPAR-dependent and PPAR-independent pathways, of which the latter appears to predominate.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. M. Bivol, M. Hultstrom, O. A. Gudbrandsen, R. K. Berge, and B. M. Iversen Tetradecylthioacetic acid downregulates cyclooxygenase 2 in the renal cortex of two-kidney, one-clip hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1866 - R1873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Bivol, R. K. Berge, and B. M. Iversen Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R438 - R447. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Bivol, R. K. Berge, and B. M. Iversen Differential effect of tetradecythioacetic acid on the renin-angiotensin system and blood pressure in SHR and 2-kidney, 1-clip hypertension Am J Physiol Renal Physiol, September 1, 2007; 293(3): F839 - F845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grommes, G. E. Landreth, M. Sastre, M. Beck, D. L. Feinstein, A. H. Jacobs, U. Schlegel, and M. T. Heneka Inhibition of in Vivo Glioma Growth and Invasion by Peroxisome Proliferator-Activated Receptor {gamma} Agonist Treatment Mol. Pharmacol., November 1, 2006; 70(5): 1524 - 1533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. O. Iversen, D. R. Sorensen, K. J. Tronstad, O. A. Gudbrandsen, A. C. Rustan, R. K. Berge, and C. A. Drevon A bioactively modified Fatty Acid improves survival and impairs metastasis in preclinical models of acute leukemia. Clin. Cancer Res., June 1, 2006; 12(11): 3525 - 3531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dyroy, A. Yndestad, T. Ueland, B. Halvorsen, J. K. Damas, P. Aukrust, and R. K. Berge Antiinflammatory Effects of Tetradecylthioacetic Acid Involve Both Peroxisome Proliferator-Activated Receptor {alpha}-Dependent and -Independent Pathways Arterioscler Thromb Vasc Biol, July 1, 2005; 25(7): 1364 - 1369. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Frohlich, F. Machicao, and R. Wahl Action of thiazolidinediones on differentiation, proliferation and apoptosis of normal and transformed thyrocytes in culture Endocr. Relat. Cancer, June 1, 2005; 12(2): 291 - 303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grommes, G. E. Landreth, U. Schlegel, and M. T. Heneka The Nonthiazolidinedione Tyrosine-Based Peroxisome Proliferator-Activated Receptor {gamma} Ligand GW7845 Induces Apoptosis and Limits Migration and Invasion of Rat and Human Glioma Cells J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 806 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Grav, K. J. Tronstad, O. A. Gudbrandsen, K. Berge, K. E. Fladmark, T. C. Martinsen, H. Waldum, H. Wergedahl, and R. K. Berge Changed Energy State and Increased Mitochondrial {beta}-Oxidation Rate in Liver of Rats Associated with Lowered Proton Electrochemical Potential and Stimulated Uncoupling Protein 2 (UCP-2) Expression: EVIDENCE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{alpha} INDEPENDENT INDUCTION OF UCP-2 EXPRESSION J. Biol. Chem., August 15, 2003; 278(33): 30525 - 30533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Berge, K. J. Tronstad, P. Bohov, L. Madsen, and R. K. Berge Impact of mitochondrial {beta}-oxidation in fatty acid-mediated inhibition of glioma cell proliferation J. Lipid Res., January 1, 2003; 44(1): 118 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Madsen, M. Guerre-Millo, E. N. Flindt, K. Berge, K. J. Tronstad, E. Bergene, E. Sebokova, A. C. Rustan, J. Jensen, S. Mandrup, et al. Tetradecylthioacetic acid prevents high fat diet induced adiposity and insulin resistance J. Lipid Res., May 1, 2002; 43(5): 742 - 750. [Abstract] [Full Text] [PDF]
|
|